***Please note that, in order to access these course materials, you must create a user profile if you do not already have one. Your profile one ScientiaCME's website is unrelated to your profile on North American Thrombosis Forum's (NATF's) website.***
This activity addresses the complexity of managing patients with obesity who require anticoagulation, with a particular focus on the use of direct oral anticoagulants (DOACs). As obesity has become increasingly common, how to best treat these patients with anticoagulation is a frequently encountered clinical question. In this program, speakers from several subspecialties (endocrinology, cardiology, hematology, and bariatric surgery) review the current medical literature on DOAC use in patients with obesity and provide their unique perspectives to address this question. The activity concludes with a case-based debate and Q&A session to facilitate interdisciplinary discussion and provide insights on best management strategies.
The content of this internet enduring material activity was originally presented as part of a live event.
Physicians, nurse practitioners, physician assistants, pharmacists, and other clinicians specializing in:
Supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
Participation in this activity is free of charge.
Release Date: May 09, 2022 -- Expiration Date: May 08, 2023
Faculty: Multiple Faculty,
An Internist’s Perspective: Understanding Obesity and its Management
Judy Shiau, MD, Dipl.of ABOM – Associate Professor, Division of Endocrinology and Metabolism and Program Director for the Bariatric Medicine Fellowship at the University of Ottawa; General Internist and Medical Director of LEAF Weight Management Clinic
A Cardiologist’s Perspective: How I Treat my Patients with Obesity and CVD
(including AFib)
Aaron Aday, MD, MSc – Investigator, Vanderbilt Translational and Clinical Cardiovascular Research Center at Vanderbilt University Medical Center
A Hematologist’s Perspective: How I Treat my Patients with Obesity and VTE
Tzu-Fei Wang, MD, MPH – Associate Professor of Medicine at The University of Ottawa in the Division of Hematology
A Bariatric Surgeon’s Perspective: How I Treat my Anticoagulated Patients
Undergoing Bariatric Surgery
Malcolm K. Robinson, MD – Associate Professor at Harvard Medical School; Vice Chairman of the Department of Surgery for Clinical Operations, Surgical Director of Perioperative Services, and Director of the Nutrition Support Service at Brigham and Women’s Hospital
Case-Based Debates and Q&A:
Moderated by Dr. Allen Taylor, MD – Chairman of Cardiology at MedStar Heart and Vascular Institute
Case 1: DOAC Use in a Patient with Obesity and AFib
Aaron Aday, MD, MSc – Investigator, Vanderbilt Translational and Clinical Cardiovascular Research Center at Vanderbilt University Medical Center
Case 2: DOAC Use in a Patient with Obesity and VTE
Tzu-Fei Wang, MD, MPH – Associate Professor of Medicine at The University of Ottawa in the Division of Hematology
Case 3: DOAC Use in a Patient Who Has Undergone Bariatric Surgery
Malcolm K. Robinson, MD – Associate Professor at Harvard Medical School; Vice Chairman of the Department of Surgery for Clinical Operations, Surgical Director of Perioperative Services, and Director of the Nutrition Support Service at Brigham and Women’s Hospital
Panel Discussion
By the end of the session the participant will be able to:
ACCME Activity #202289556
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
Individuals with no conflicts of interest to disclose:
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.